US dollars <a href=" http://www.sleepbox.co.uk/order-periactin-online.pdf ">cheap periactin</a> Roth Capital Partners reinstated its "buy" rating on themedical device maker's stock with a $10 price target, sayingpositive data from the trials on Cytori's cell therapy forchronic ischemic heart failure would boost its U.S. profile.